Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-16

Clinical Trial Update: Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study [NA]

View source ↗

Summary

This clinical trial update notes that a pilot study of carbohydrate restriction plus SGLT2 inhibition for patients with renal impairment and altered glucose met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Department of Nephrology Clinic Ottakring Vienna | Conditions: Chronic Kidney Diseases, Diabetes Mellitus | NA | Status: TERMINATED